Brief: Yichang Hec Changjiang Pharmaceutical Announces Febuxostat Tablets Approved To Launch From Nmpa
14/05/2021 11:01
May 14 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* ANNOUNCES FEBUXOSTAT TABLETS APPROVED TO LAUNCH FROM NMPA
Source text for Eikon: ID:nHKS8cCtgk
Further company coverage: 1558.HK
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million